Intraprocedural anticoagulation in patients on non-vitamin K antago-nist oral anticoagulants undergoing catheter ablation for atrial fibrillation
Atrial fibrillation (AF)catheter ablation, usually performed in patients on oral anticoagulation—either traditional vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulants(NOACs)-entails contrasting risks: on the one hand, a risk of major bleeding, including hemopericardium, and on the other hand, a high transient procedure-related risk of thromboembolism that necessitates particularly rigorous anticoagulation throughout the procedure.
39
2020-10-16(万方平台首次上网日期,不代表论文的发表时间)
共5页
515-519